A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient

被引:12
|
作者
Liu, Yihui [1 ]
Xu, Jiang [2 ]
Tao, Wanyun [3 ]
Yu, Rong [4 ]
Zhang, Xinjiang [1 ,2 ]
机构
[1] Yangzhou Univ, Dept Neurol, Affiliated Hosp, Yangzhou 225000, Jiangsu, Peoples R China
[2] Yangzhou Univ, Med Sch, Yangzhou, Jiangsu, Peoples R China
[3] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[4] Cent S Univ, XiangYa Hosp 2, Dept Anesthesiol, Changsha, Hunan, Peoples R China
关键词
Hypertriglyceridemia; HTG; LMF1; Compound mutation; LIPOPROTEIN-LIPASE; ENDOPLASMIC-RETICULUM; TRIGLYCERIDE; DEFICIENCY; ENZYME; LETHAL; GENE;
D O I
10.5551/jat.44537
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LPL), apolipoprotein CII (APOC2), apolipoprotein AV (APOA5), glycosylphosphatidylinositol anchored high-density lipoprotein-binding protein 1 (GPIHBP1), lipase maturation factor 1 (LMF1), and glycerol-3 phosphate dehydrogenase 1 (GPD1) are responsible for HTG by using genomic microarrays and next-generation sequencing. The aim of this study was to identify genetic lesions in patients with HTG. Method: Our study included a family of seven members from Jiangsu province across three generations. The proband was diagnosed with severe HTG, with a plasma triglyceride level of 38.70 mmol/L. Polymerase chain reaction (PCR) and Sanger sequencing were performed to explore the possible causative gene mutations for this patient. Furthermore, we measured the post-heparin LPL and hepatic lipase (HL) activities using an antiserum inhibition method. Results: A compound heterozygous mutation in the LMF1 gene (c.257C>T/p.P86L and c.1184C>T/p. T3951) was identified and co-segregated with the affected patient in this family. Both mutations were predicted to be deleterious by three bioinformatics programs (Polymorphism Phenotyping-2, Sorting Intolerant From Tolerant, and MutationTaster). The levels of the plasma post-heparin LPL and HL activities in the proband (57 and 177 mU/mL) were reduced to 24% and 75%, respectively, compared with those assayed in the control subject with normal plasma triglycerides. Conclusion: A compound heterozygous mutation of LMF1 was identified in the presenting patient with severe HTG. These findings expand on the spectrum of LMF1 mutations and contribute to the genetic diagnosis and counseling of families with HTG.
引用
收藏
页码:136 / 144
页数:9
相关论文
共 50 条
  • [31] A novel compound heterozygous mutation in TTC8 identified in a Japanese patient
    Sato, Shigeru
    Morimoto, Takeshi
    Hotta, Kikuko
    Fujikado, Takashi
    Nishida, Kohji
    HUMAN GENOME VARIATION, 2019, 6 (1)
  • [32] Analysis of a pedigree with inherited factor V deficiency caused by compound heterozygous mutation
    郭跃丽
    China Medical Abstracts(Internal Medicine), 2021, 38 (02) : 118 - 119
  • [33] Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser447-Ter LPL mutation
    Zhu, YJ
    Bujo, H
    Takahashi, K
    Taira, K
    Kobayashi, J
    Koshikawa, H
    Sasaki, Y
    Kanoh, T
    Saito, Y
    CLINICA CHIMICA ACTA, 2001, 308 (1-2) : 139 - 146
  • [34] A novel compound heterozygous mutation in the arginase-1 gene identified in a Chinese patient with argininemia A case report
    Cui, Dongqing
    Liu, Yanxia
    Jin, Liang
    Hu, Liping
    Cao, Lili
    MEDICINE, 2020, 99 (32) : E21634
  • [35] Hereditary Spherocytosis Caused by a Novel Compound Heterozygous Mutation of SPTA1 and Autoimmune Hepatitis in a Pediatric Patient
    Qin, Yu-Mei
    Chen, Yan-Yun
    Liao, Lin
    Chen, Min
    Lin, Fa-Quan
    IRANIAN JOURNAL OF PEDIATRICS, 2023, 33 (01)
  • [36] A novel compound heterozygous mutation of MYSM1 gene in a patient with bone marrow failure syndrome 4
    Zhan, X.
    Zhao, A.
    Wu, B.
    Yang, Y.
    Wan, L.
    Tan, P.
    Huang, J.
    Lu, Y.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2021, 78 (04) : 239 - 243
  • [37] Multimodal imaging findings in a patient with type I sialidosis with a compound heterozygous mutation in the NEU1 gene
    Wan, Chao
    Lin, Meina
    Jiang, Miao
    Hua, Rui
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2021, 11 (09) : 4219 - 4222
  • [38] A Case Report of a Novel Compound Heterozygous Mutation in a Brazilian Patient with Deficiency of IL1RA (DIRA)
    Mendonca, L. O.
    Grossi, A.
    Torres Cordova, P.
    Amorim, L. C.
    Kalil, J.
    Castro, F. M.
    Pontillo, A.
    Ceccherini, I.
    Gattorno, M.
    Toledo Barros, M. T.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S19 - S19
  • [39] A new heterozygous mutation in GP1BA gene responsible for macrothrombocytopenia
    Ghalloussi, Dorsaf
    Saut, Noemie
    Bernot, Denis
    Pillois, Xavier
    Rameau, Philippe
    Sebahoun, Gerard
    Alessi, Marie-Christine
    Raslova, Hana
    Baccini, Veronique
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (03) : 503 - 506
  • [40] Compound Heterozygous Mutation of Rag1 Leading to Omenn Syndrome
    Matthews, Adam G. W.
    Briggs, Christine E.
    Yamanaka, Keiichi
    Small, Trudy N.
    Mooster, Jana L.
    Bonilla, Francisco A.
    Oettinger, Marjorie A.
    Butte, Manish J.
    PLOS ONE, 2015, 10 (04):